0001893119-21-000002.txt : 20220103 0001893119-21-000002.hdr.sgml : 20220103 20211230173308 ACCESSION NUMBER: 0001893119-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20211230 EFFECTIVENESS DATE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clade Therapeutics, Inc. CENTRAL INDEX KEY: 0001893119 IRS NUMBER: 853881133 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-427506 FILM NUMBER: 211533804 BUSINESS ADDRESS: STREET 1: 1 KENDALL SQUARE, SUITE B200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 415-886-7710 MAIL ADDRESS: STREET 1: 1 KENDALL SQUARE, SUITE B200 CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001893119 Clade Therapeutics, Inc. 1 KENDALL SQUARE, SUITE B200 CAMBRIDGE MA MASSACHUSETTS 02139 415-886-7710 DELAWARE None None Corporation true 2020 Chad A. Cowan c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Martin Murphy c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Director Neil White c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Director Jim Glasheen c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Daniel Vasella c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Director Leandro Vetcher c/o Clade Therapeutics, Inc. 1 Kendall Square, Suite B200 Cambridge MA MASSACHUSETTS 02139 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2021-12-17 true true false 0 66000 42000 24000 Shares issued as partial consideration for rights granted to Issuer under certain license agreement. false 1 0 0 0 false Clade Therapeutics, Inc. /s/ Leandro Vetcher Leandro Vetcher Chief Operating Officer 2021-12-30